Unusual Options Activity Update: KERX, AVP, GRPN, STD, DANG, GPS
Implied Volatility Mover
Implied volatility in the options on Kerx Biopharmaceuticals (KERX) is lower today after the company released trial results for its experimental treatment for colorectal cancer. The stock is down on the results, down $3.29 to $1.69 per share, on heavy volume of 29 million shares, which is 10X the expected volume for the biotech. Meanwhile, 25,000 calls and 19,000 puts traded in KERX and levels of implied volatility are down 30 percent, but still elevated at 124, now that trial results have been announced.
Volume Signals
Avon Products (AVP) options volume is running 25X the (22-day) average, with 49,000 contracts traded and call volume accounting for 59 percent of the volume..
Kerx Biopharmaceuticals (KERX) options volume is 3.5X the average daily, with 42,000 contracts traded and call volume representing for 57 percent of the activity.
Groupon (GRPN) options volume is running 3X the average daily, with 36,000 contracts traded and put volume accounting for 60 percent of the activity.
Increasing options activity is also being seen in Banco Santander (STD), eCommerce Dang Dang (DANG), and Gap Stores (GPS).
-------------------------------------------------------------------------------------
Disclaimers
This article is provided for informational purposes only. No statementin this article should be construed as a recommendation to buy or sell asecurity or to provide investment advice. The content provided has beenobtained from sources deemed reliable but is not guaranteed as toaccuracy and completeness. optionsXpress makes every effort to providetimely information to its recipients but cannot guarantee specificdelivery times due to factors beyond our control.
Derivatives involve substantial risk and are not appropriate for all investors. Please read the "Disclosure Statement for Futures and Options" prior to investing in futures or options.
"
View Joseph Cusick's post archive >

